Jon P. Stonehouse

CIK: 0001385496

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (5.0%)

Derivative conversions

Awards (A)7 (35.0%)

Compensation grants

Other (G, F, J, C, D, …)12 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BCRX

BIOCRYST PHARMACEUTICALS INC

Director

MTSR

Metsera, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 31, 2026
Award(A)
Direct
644 shares at avg. $9.70$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 11, 2026
Award(A)
Direct
15.3K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
May 29, 2026
Award(A)
Direct
631 shares at avg. $8.91$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 2, 2026
Exercise(M)
Direct
306K shares at avg. $3.22$985K
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 2, 2026
Disposition(D)
Direct
306K shares at avg. $8.64$2.6M
BCRX
BIOCRYST PHARMACEUTICALS INC
Feb 27, 2026
Award(A)
Direct
421 shares at avg. $8.75$4K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2025
Tax Payment(F)
Direct
61.8K shares at avg. $7.41$458K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 18, 2025
Gift(G)
Direct
20K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 18, 2025
Gift(G)
Indirect
10K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 18, 2025
Gift(G)
Indirect
10K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 12, 2025
Tax Payment(F)
Direct
27.4K shares at avg. $7.57$207K
MTSR
Metsera, Inc.
Nov 13, 2025
Award(A)
Restricted Stock Unit
Direct
2.7K shares-
MTSR
Metsera, Inc.
Nov 13, 2025
Disposition(D)
Direct
2.7K shares-
MTSR
Metsera, Inc.
Apr 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
47.7K shares at avg. $19.81-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 20, 2024
Gift(G)
Indirect
10K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 20, 2024
Gift(G)
Indirect
10K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 20, 2024
Gift(G)
Direct
20K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2024
Tax Payment(F)
Direct
14K shares at avg. $7.39$104K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2024
Award(A)
Direct
362.1K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 14, 2024
Tax Payment(F)
Direct
27.5K shares at avg. $7.53$207K

		Type	Shares	Price		Ownership
Aug 31, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	644	$9.70	$6,247	Direct
Jun 11, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	15,294	-	$0	Direct
May 29, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	631	$8.91	$5,622	Direct
Mar 2, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	305,995	$3.22	$985,304	Direct
Mar 2, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Disposition(D)	305,995	$8.64	$2,643,797	Direct
Feb 27, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	421	$8.75	$3,684	Direct
Dec 19, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	61,793	$7.41	$457,886	Direct
Dec 18, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	20,000	-	-	Direct
Dec 18, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	10,000	-	-	Indirect
Dec 18, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	10,000	-	-	Indirect
Dec 12, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	27,368	$7.57	$207,176	Direct
Nov 13, 2025	MTSR Metsera, Inc.	Award(A) Restricted Stock Unit	2,688	-	-	Direct
Nov 13, 2025	MTSR Metsera, Inc.	Disposition(D)	2,688	-	-	Direct
Apr 28, 2025	MTSR Metsera, Inc.	Award(A) Stock Option (Right to Buy)	47,730	$19.81	-	Direct
Dec 20, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	10,000	-	$0	Indirect
Dec 20, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	10,000	-	$0	Indirect
Dec 20, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Gift(G)	20,000	-	$0	Direct
Dec 19, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	14,010	$7.39	$103,534	Direct
Dec 19, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	362,100	-	$0	Direct
Dec 14, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	27,525	$7.53	$207,263	Direct

1-20 of 20 transactions

About Stonehouse Jon P

Stonehouse Jon P (SEC CIK 0001385496) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX) and Director of Metsera, Inc. (MTSR).

Signal8 holds 12 ownership filings by Stonehouse Jon P (1 Form 3, 11 Form 4), filed between Dec 17, 2024 and Sep 2, 2026. Those filings report 20 transactions, from Dec 14, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Stonehouse Jon P's filings is in DURHAM, NC.

Recent filings by Stonehouse Jon P

Aug 31, 2026: Grant or award of BCRX shares (Form 4, code A).
Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
May 29, 2026: Grant or award of BCRX shares (Form 4, code A).
Mar 2, 2026: Option exercise of BCRX shares (Form 4, code M).
Mar 2, 2026: Disposition to issuer transaction of BCRX shares (Form 4, code D).

Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)

Milne Jill C., Director
MILANO VINCENT, Director
McKee Amy E, Director
Frank Steven, Director
Galson Steven K, Director
LEVIN ALAN G, Director

How to read Form 4 transaction codes